KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EPS (Weighted Average and Diluted) (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.08 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 20.0% to $0.08 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.51 through Dec 2025, down 3.77% year-over-year, with the annual reading at $0.51 for FY2025, 3.77% down from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.08 in Q4 2025 for Hims & Hers Health, up from $0.06 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.32 in Q3 2024 to a low of -$0.34 in Q1 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.0 across 5 years, with a median of -$0.04 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 100.0% in 2021 and later surged 900.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.16 in 2021, then skyrocketed by 68.75% to -$0.05 in 2022, then skyrocketed by 120.0% to $0.01 in 2023, then soared by 900.0% to $0.1 in 2024, then decreased by 20.0% to $0.08 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for HIMS at $0.08 in Q4 2025, $0.06 in Q3 2025, and $0.17 in Q2 2025.